Parnrada Nulsopapon

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Genetic Diversity

Multidrug Resistant

Klebsiella Pneumoniae

Emergency Department

Top Venues

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Parnrada Nulsopapon, Manat Pongchaidecha, Worapong Nasomsong, Pitimon Polwichai, Sirilada Suphankong, Pantip Sirichote, Siriwan Chaisomboonpan, Wichai Santimaleeworagun
Antimicrobial Activity Profiles and Potential Antimicrobial Regimens against Carbapenem-Resistant Enterobacterales Isolated from Multi-Centers in Western Thailand. Antibiotics (Basel, Switzerland) 11 (3) (2022)
Worapong Nasomsong, Parnrada Nulsopapon, Dhitiwat Changpradub, Supanun Pungcharoenkijkul, Patomroek Hanyanunt, Tassanawan Chatreewattanakul, Wichai Santimaleeworagun
Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant Pseudomonas aeruginosa . Antibiotics (Basel, Switzerland) 11 (4) (2022)
Parnrada Nulsopapon, Worapong Nasomsong, Manat Pongchaidecha, Dhitiwat Changpradub, Piraporn Juntanawiwat, Wichai Santimaleeworagun
Correction: Nulsopapon et al. The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant Klebsiella pneumoniae Isolates. Antibiotics 2021, 10 , 736. Antibiotics (Basel, Switzerland) 11 (6) (2022)
Parnrada Nulsopapon, Worapong Nasomsong, Manat Pongchaidecha, Dhitiwat Changpradub, Piraporn Juntanawiwat, Wichai Santimaleeworagun
The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant Klebsiella pneumoniae Isolates. Antibiotics (Basel, Switzerland) 10 (6) (2021)